{
  "ticker": "VTYX",
  "company_name": "Ventyx Biosciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05655299",
      "title": "VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Psoriasis",
      "start_date": "2022-11-17",
      "completion_date": "2023-12-20",
      "enrollment": 0,
      "sponsor": "Ventyx Biosciences, Inc"
    },
    {
      "nct_id": "NCT05715125",
      "title": "VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Psoriatic Arthritis",
      "start_date": "2023-01-31",
      "completion_date": "2024-01-02",
      "enrollment": 0,
      "sponsor": "Ventyx Biosciences, Inc"
    },
    {
      "nct_id": "NCT05688852",
      "title": "VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Crohn Disease",
      "start_date": "2023-01-25",
      "completion_date": "2024-12-20",
      "enrollment": 0,
      "sponsor": "Ventyx Biosciences, Inc"
    }
  ],
  "summary": {
    "total_trials": 3,
    "by_phase": {
      "PHASE2": 3
    },
    "by_status": {
      "TERMINATED": 3
    },
    "active_trials": 0,
    "completed_trials": 0,
    "conditions": [
      "Crohn Disease",
      "Psoriasis",
      "Psoriatic Arthritis"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:54.134691",
    "search_query": "Ventyx Biosciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Ventyx+Biosciences,+Inc."
  }
}